研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2025 年的期刊文章 · 第 23 页
共 1491 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2025-03-21 到 2025-03-12。
按期刊、按主题看 →
Biometrics Networks & Graphs · 发表于 2025-03-21
Tong Lu, Yuan Zhang, Vince Lyzinski, Chuan Bi, Peter Kochunov, Elliot Hong, Shuo Chen
摘要
The joint analysis of multimodal neuroimaging data is vital in brain research, revealing complex interactions between brain structures and functions. Our study is motivated by the analysis of a vast dataset of brain functional connectivity (FC) and multimodal structural imaging (SI) features from the UK Biobank. Specifically, we aim to investigate the effects of SI features, such as white matter microstructure integrity (WMMI) and cortical thickness, on the whole-brain functional connectome network. This analysis is inherently challenging due to the extensive structural-functional associations and the intricate network patterns present in multimodal high-dimensional neuroimaging data. To bridge methodological gaps, we developed a novel multi-level sub-graph extraction method (dense bipartite with nested unipartite graph) within a matrix(network)-on-vector regression model. This method identifies subsets of spatially specific SI features that intensely and systematically influence FC sub-networks, while effectively suppressing false positives in large-scale datasets. Applying our method to a multimodal neuroimaging dataset of 4242 participants ffrom the UK Biobank, we evaluated the effects of whole-brain WMMI and cortical thickness on resting-state FC. Our findings indicate that the WMMI in corticospinal tracts and inferior cerebellar peduncle significantly affect functional connections of sensorimotor, salience, and executive sub-networks, with an average correlation of 0.81 ($p < 0.001$).
SMMR Machine Learning Nonparametric & Semiparametric High-Dimensional · 发表于 2025-03-21
Guillermo Briseño Sanchez, Nadja Klein, Hannah Klinkhammer, Andreas Mayr
摘要
Motivated by challenges in the analysis of biomedical data and observational studies, we develop statistical boosting for the general class of bivariate distributional copula regression with arbitrary marginal distributions, which is suited for binary, count, continuous or mixed outcomes. To arrive at a flexible model for the entire conditional distribution, not only the marginal distribution parameters but also the copula parameters are related to covariates through additive predictors. We suggest estimation by means of an adapted component-wise gradient boosting algorithm. A key benefit of boosting as opposed to classical likelihood or Bayesian estimation is the implicit data-driven variable selection mechanism as well as shrinkage. To the best of our knowledge, our implementation is the only one that combines a wide range of covariate effects, marginal distributions, copula functions, and implicit data-driven variable selection. We showcase the versatility of our approach to data from genetic epidemiology, healthcare utilization and childhood undernutrition. Our developments are implemented in the R package gamboostLSS , fostering transparent and reproducible research.
Biometrics Longitudinal Data Bayesian Methods · 发表于 2025-03-21
Christopher S McMahan, Chase N Joyner, Joshua M Tebbs, Christopher R Bilder
摘要
Laboratories use group (pooled) testing with multiplex assays to reduce the time and cost associated with screening large populations for infectious diseases. Multiplex assays test for multiple diseases simultaneously, and combining their use with group testing can lead to highly efficient screening protocols. However, these benefits come at the expense of a more complex data structure which can hinder surveillance efforts. To overcome this challenge, we develop a general Bayesian framework to estimate a mixed multivariate probit model with data arising from any group testing protocol that uses multiplex assays. In the formulation of this model, we account for the correlation between true disease statuses and heterogeneity across population subgroups, and we provide for automated variable selection through the adoption of spike and slab priors. To perform model fitting, we develop an attractive posterior sampling algorithm which is straightforward to implement. We illustrate our methodology through numerical studies and analyze chlamydia and gonorrhea group testing data collected by the State Hygienic Laboratory at the University of Iowa.
SiM High-Dimensional · 发表于 2025-03-20
Xianwei Li, Richard J. Cook, Liqun Diao
摘要
Multistate models offer a natural framework for studying many chronic disease processes. Interest often lies in identifying which among a large list of candidate variables play a role in the progression of such processes. We consider the problem of variable selection for progressive multistate processes under intermittent observation based on penalized log‐likelihood. An Expectation‐Maximization (EM) algorithm is developed such that the maximization step can exploit existing software for penalized Poisson regression thereby allowing for the use of common penalty functions. Simulation studies show good performance in identifying important markers with different penalty functions. In a motivating application involving a cohort of patients with psoriatic arthritis, we identify which, among a large group of candidate HLA markers, are associated with rapid disease progression.
SMMR Nonparametric & Semiparametric Bayesian Methods Latent Variables & Mixtures · 发表于 2025-03-20
Hong-Xia Zhang, Yu-Zhu Tian, Yue Wang, Mao-Zai Tian
摘要
In clinical medical health research, individual measurements sometimes appear as a mixture of ordinal and continuous responses. There are some statistical correlations between response indicators. Regarding the joint modeling of mixed responses, the effect of a set of explanatory variables on the conditional mean of mixed responses is usually studied based on a mean regression model. However, mean regression results tend to underperform for data with non-normal errors and outliers. Quantile regression (QR) offers not only robust estimates but also the ability to analyze the impact of explanatory variables on various quantiles of the response variable. In this paper, we propose a joint QR modeling approach for mixed ordinal and continuous responses and apply it to the analysis of a set of obesity risk data. Firstly, we construct the joint QR model for mixed ordinal and continuous responses based on multivariate asymmetric Laplace distribution and a latent variable model. Secondly, we perform parameter estimation of the model using a Markov chain Monte Carlo algorithm. Finally, Monte Carlo simulation and a set of obesity risk data analysis are used to verify the validity of the proposed model and method.
SMMR Survival Analysis High-Dimensional Machine Learning · 发表于 2025-03-20
Tingting Cai, Mengqi Xie, Tao Hu, Jianguo Sun
摘要
We consider simultaneous variable selection and estimation for a deep neural network-based partially linear Cox model and propose a novel penalized approach. In particular, a two-step iterative algorithm is developed with the use of the minimum information criterion to ensure sparse estimation. The proposed method circumvents the curse of dimensionality while facilitating the interpretability of linear covariate effects on survival, and the algorithm greatly reduces the computational burden by avoiding the need to select the optimal tuning parameters that is usually required by many other popular penalties. The convergence rate and asymptotic properties of the resulting estimator are established along with the consistency of variable selection. The performance of the procedure is demonstrated through extensive simulation studies and an application to a myeloma dataset.
SiM Clinical Trials · 发表于 2025-03-20
Xiaotian Chen, Jun Yu, Hongjian Zhu, Li Wang
摘要
The importance of covariate adjustment in clinical trials has been underscored by the U.S. FDA's guidance. Inference, with or without covariates, after implementing covariate adaptive randomization (CAR), is garnering increased interest. This paper investigates the sequential monitoring of covariate‐adaptive randomized clinical trials through non‐parametric methods, a critical advancement for enhancing the precision and efficiency of medical research. CAR, which incorporates baseline patient characteristics into the randomization process, aims to mitigate the risk of confounding and improve the balance of covariates across treatment groups, thereby addressing patients' heterogeneity. Although CAR is known for its benefits in reducing biases and enhancing statistical power, its integration into sequentially monitored clinical trials—a standard practice—poses methodological challenges, particularly in controlling the type I error rate. By employing a non‐parametric approach, we demonstrate through theoretical proofs and numerical analyses that our methods effectively control the type I error rate and surpass traditional randomization and analysis methods. This paper not only fills a gap in the literature on sequential monitoring of CAR without model misspecification but also proposes practical solutions for enhancing trial design and analysis, thereby contributing significantly to the field of clinical research.
SMMR Survival Analysis Causal Inference Bayesian Methods · 发表于 2025-03-20
Jonathan A Race, Amy S Ruppert, Yvonne Efebera, Michael L Pennell
摘要
Time-to-event data often violate the proportional hazards assumption under which the log-rank test is optimal. Such violations are especially common in the sphere of biological and medical data where heterogeneity due to unmeasured covariates or time varying effects are common. A variety of parametric survival models have been proposed in the literature which make more appropriate assumptions on the hazard function, at least for certain applications. One such model is derived from the first hitting time paradigm which assumes that a subject’s event time is determined by a latent stochastic process reaching a threshold value. Several random effects specifications of the first hitting time model have also been proposed which allow for better modeling of data with unmeasured covariates. We propose a Bayesian model which loosens assumptions on the mixing distribution inherent in the random effects first hitting time models currently in use and we do so in a manner which is ideally suited for testing for effects of ordinal treatment variables. We demonstrate via a simulation study that the proposed model has better power than log-rank based methods in detecting ordinal treatment effects in the presence of nonproportional hazards. Additionally, we show that the proposed model is almost as powerful as log-rank based methods when the proportional hazards assumption holds. We also apply the proposed methodology to two biomedical data sets: a toxicity study in rodents and an observational study of cancer patients.
SMMR Clinical Trials Longitudinal Data · 发表于 2025-03-20
Priyanka Majumder, Siuli Mukhopadhyay, Bo Wang, Samiran Ghosh
摘要
Cluster or group randomized trials (CRTs) are increasingly used for behavioral as well as system-level interventions in many areas e.g. medicine, psychotherapy, policy, and health service research etc. Sample size determination for each level at the design stage is always a key requirement for any intervention trial including CRT. This work addresses this important issue for a four-level longitudinal CRT via detecting the intervention effect over time. A random intercept and random slope mixed effects linear regression model, including a time-by-intervention interaction is used for modeling. Closed-form expression of the power function and sample size for each level are determined to detect the interaction effect. Other than statistical power consideration, several other factors need attention while designing such CRTs. Optimal allocations accounting for subject attrition and cost constraints have been determined here. How sample size determination based on fixed and random slope models affects when between-subject variations in outcome are anticipated to be significant is also studied. The effect of ignoring cluster levels in a four-level CRT, which is often the case in the absence of an appropriate four-level model, is studied in details. Lastly, the proposed model is illustrated via a real-life human immunodeficiency virus prevention study conducted in the Bahamas.
Biometrics Causal Inference Clinical Trials Missing Data & Measurement Error · 发表于 2025-03-20
Florian Stijven, Trung Dung Tran, Ellen Driessen, Ariel Alonso Abad, Geert Molenberghs, Geert Verbeke, Iven Van Mechelen
摘要
An important aspect of precision medicine is the tailoring of treatments to specific patient types. Nowadays, various methods are available to estimate for this purpose so-called optimal treatment regimes, that is, decision rules for treatment assignment that map patterns of pretreatment characteristics to treatment alternatives and that maximize the expected patient benefit. However, the application of these methods to real-life data has been limited and comes with nonstandard statistical issues. In search of best practices, we reanalyzed data from a randomized clinical trial for the treatment of dysthymic disorder. While the original objective of this trial was to detect a marginally best treatment alternative, we wanted to estimate an optimal treatment regime using 2 prominent estimation methods: Q-learning and value search estimation. An important obstacle in the dataset under study was the occurrence of missing values. This was handled with multiple imputation, a thoughtful implementation of which, however, implied several challenges. Other challenges were implied by the concrete implementation of value search estimation. In this paper, all the choices we have made in the analysis to handle the aforementioned issues are detailed together with a motivation and a description of possible alternatives. Accordingly, this paper may serve as a guide to apply optimal treatment regime estimation in data-analytic practice.
SMMR Clinical Trials Causal Inference · 发表于 2025-03-20
Shu-Han Wan, Hwa-Chi Liang, Hsiao-Hui Tsou, Hong-Dar Wu, Suojin Wang
摘要
Multiregional clinical trials (MRCTs) have become a standard strategy for pharmaceutical product development worldwide. The heterogeneity of regional treatment effects is anticipated in an MRCT. For a two-group comparative study in an MRCT, patient assignments, including regional weights and treatment allocation ratios, are predetermined under the same protocol. In practice, the observed patient assignments at the final analysis stage are often not equal to the predetermined patient assignments, which may impact the accuracy of estimating the overall treatment effect and may lead to a biased estimator. In this study, we use a discrete random effects model (DREM) to account for the heterogeneous treatment effect across regions in an MRCT and propose a bias-adjusted estimator of the overall treatment effect through a naïve estimator conditioned on ancillary statistics based on the observed patient assignments at the final analysis stage in the trial. We also perform power analysis for the overall treatment effect and determine the overall sample size for the bias-adjusted estimator with the DREM. Results of simulation studies are given to illustrate applications of the proposed approach. Finally, we provide an example to demonstrate the implementation of the proposed approach.
SMMR Testing & Uncertainty · 发表于 2025-03-20
Shirui Wang, Shuangfei Shi, Gengsheng Qin
摘要
In medical diagnostic studies, the Youden index plays a crucial role as a comprehensive measurement of the diagnostic test effectiveness, aiding in determining the optimal threshold values by maximizing the sum of sensitivity and specificity. However, in clinical practice, verification of true disease status might be partially missing and estimators based on partially validated subjects are usually biased. While verification bias-corrected estimation methods for the receiver operating characteristic curve have been widely studied, no such results have been specifically developed for the Youden index. In this paper, we propose bias-corrected interval estimation methods for the Youden index of a continuous test under the missing-at-random assumption. Based on four estimators (full imputation (FI), mean score imputation, inverse probability weighting, and the semiparametric efficient (SPE)) introduced by Alonzo and Pepe for handling verification bias, we develop multiple confidence intervals for the Youden index by applying bootstrap resampling and the method of variance estimates recovery (MOVER). Extensive simulation and real data studies show that when the disease model is correctly specified, MOVER-FI intervals yield better coverage probability. We also observe a tradeoff between methods when the verification proportion is low: Bootstrap approaches achieve higher accuracy, while MOVER approaches deliver greater precision. Remarkably, bootstrap-SPE interval exhibit appealing doubly robustness to model misspecification and perform adequately across almost all scenarios considered. Based on our findings, we recommend using the bootstrap-SPE intervals when the true disease model is unknown, and the MOVERws-FI interval if the true disease model can be well approximated.
SMMR Clinical Trials Diagnostics & Prediction Bayesian Methods · 发表于 2025-03-20
Libby Daniells, Pavel Mozgunov, Helen Barnett, Alun Bedding, Thomas Jaki
摘要
Basket trials test a single therapeutic treatment on several patient populations under one master protocol. A desirable adaptive design feature is the ability to incorporate new baskets to an ongoing trial. Limited basket sample sizes can result in reduced power and precision of treatment effect estimates, which could be amplified in added baskets due to the shorter recruitment time. While various Bayesian information borrowing techniques have been introduced to tackle the issue of small sample sizes, the impact of including new baskets into the borrowing model has yet to be investigated. We explore approaches for adding baskets to an ongoing trial under information borrowing. Basket trials have pre-defined efficacy criteria to determine whether the treatment is effective for patients in each basket. The efficacy criteria are often calibrated a-priori in order to control the basket-wise type I error rate to a nominal level. Traditionally, this is done under a null scenario in which the treatment is ineffective in all baskets, however, we show that calibrating under this scenario alone will not guarantee error control under alternative scenarios. We propose a novel calibration approach that is more robust to false decision making. Simulation studies are conducted to assess the performance of the approaches for adding a basket, which is monitored through type I error rate control and power. The results display a substantial improvement in power for a new basket, however, this comes with potential inflation of error rates. We show that this can be reduced under the proposed calibration procedure.
SMMR Missing Data & Measurement Error Causal Inference · 发表于 2025-03-20
Kimberly A Hochstedler Webb, Martin T Wells
摘要
Mediation analyses allow researchers to quantify the effect of an exposure variable on an outcome variable through a mediator variable. If a binary mediator variable is misclassified, the resulting analysis can be severely biased. Misclassification is especially difficult to deal with when it is differential and when there are no gold standard labels available. Previous work has addressed this problem using a sensitivity analysis framework or by assuming that misclassification rates are known. We leverage a variable related to the misclassification mechanism to recover unbiased parameter estimates without using gold standard labels. The proposed methods require the reasonable assumption that the sum of the sensitivity and specificity is greater than 1. Three correction methods are presented: (1) An ordinary least squares correction for Normal outcome models, (2) a multi-step predictive value weighting method, and (3) a seamless expectation-maximization algorithm. We apply our misclassification correction strategies to investigate the mediating role of gestational hypertension on the association between maternal age and pre-term birth.
SMMR Machine Learning · 发表于 2025-03-20
Fuyi Tu, Wei Ma
摘要
Randomized controlled trials (RCTs) are pivotal for evaluating the efficacy of medical treatments and interventions, serving as a cornerstone in clinical research. In addition to randomization, achieving balances among multiple targets, such as statistical validity, efficiency, and ethical considerations, is also a central issue in RCTs. The doubly-adaptive biased coin design (DBCD) is notable for its high flexibility and efficiency in achieving any predetermined optimal allocation ratio and reducing variance for a given target allocation. However, DBCD does not account for abundant covariates that may be correlated with responses, which could further enhance trial efficiency. To address this limitation, this article explores the use of covariates in the analysis stage and evaluates the benefits of nonlinear covariate adjustment for estimating treatment effects. We propose a general framework to capture the intricate relationship between subjects’ covariates and responses, supported by rigorous theoretical derivation and empirical validation via simulation study. Additionally, we introduce the use of sample splitting techniques for machine learning methods under DBCD, demonstrating the effectiveness of the corresponding estimators in high-dimensional cases. This paper aims to advance both the theoretical research and practical application of DBCD, thereby achieving more accurate and ethical clinical trials.
SMMR Causal Inference Survival Analysis · 发表于 2025-03-20
Zhisong Zhao, Huijuan Ma, Yong Zhou
摘要
The causal effect of a treatment on a censored outcome is often of fundamental interest and instrumental variable (IV) is a useful tool to tame bias caused by unmeasured confounding. The two-stage least squares commonly used for IV analysis in linear regression have been developed for regression analysis in a survival context under an additive hazards model. In this work, we study a distinctive binary IV framework with censored data where the causal treatment effect is quantified through an additive hazard model for compliers. Employing the special characteristics of the binary IV and adapting the principle of conditional score, we establish a weighted estimator with explicit form. We establish the asymptotic properties of the proposed estimators and provide plug-in and perturbed variance estimators. The finite sample performance of the proposed estimator is examined by extensive simulations. The proposed method is applied to a data set from the U.S. renal data system to compare dialytic modality-specific survival for end-stage renal disease patients.
SMMR Clinical Trials · 发表于 2025-03-20
Zhiwei Zhang
摘要
The statistical efficiency of randomized clinical trials can be improved by incorporating information from baseline covariates (i.e. pre-treatment patient characteristics). This can be done in the design stage using stratified (permutated block) randomization or in the analysis stage through covariate adjustment. This article makes a connection between covariate adjustment and stratified randomization in a general framework where all regular, asymptotically linear estimators are identified as augmented estimators. From a geometric perspective, covariate adjustment can be viewed as an attempt to approximate the optimal augmentation function, and stratified randomization improves a given approximation by moving it closer to the optimal augmentation function. The efficiency benefit of stratified randomization is asymptotically equivalent to attaching an optimal augmentation term based on the stratification factor. In designing a trial with stratified randomization, it is not essential to include all important covariates in the stratification, because their prognostic information can be incorporated through covariate adjustment. Under stratified randomization, adjusting for the stratification factor only in data analysis is not expected to improve efficiency, and the key to efficient estimation is incorporating prognostic information from all important covariates. These observations are confirmed in a simulation study and illustrated using real clinical trial data.
SiM Testing & Uncertainty · 发表于 2025-03-19
Niklas Hagemann, Kathrin Möllenhoff
摘要
A common problem in numerous research areas, particularly in clinical trials, is to test whether the effect of an explanatory variable on an outcome variable is equivalent across different groups. In practice, these tests are frequently used to compare the effect between patient groups, for example, based on gender, age, or treatments. Equivalence is usually assessed by testing whether the difference between the groups does not exceed a pre‐specified equivalence threshold. Classical approaches are based on testing the equivalence of single quantities, for example, the mean, the area under the curve or other values of interest. However, when differences depending on a particular covariate are observed, these approaches can turn out to be not very accurate. Instead, whole regression curves over the entire covariate range, describing for instance the time window or a dose range, are considered and tests are based on a suitable distance measure of two such curves, as, for example, the maximum absolute distance between them. In this regard, a key assumption is that the true underlying regression models are known, which is rarely the case in practice. However, misspecification can lead to severe problems as inflated type I errors or, on the other hand, conservative test procedures. In this paper, we propose a solution to this problem by introducing a flexible extension of such an equivalence test using model averaging in order to overcome this assumption and making the test applicable under model uncertainty. Precisely, we introduce model averaging based on smooth Bayesian information criterion weights and we propose a testing procedure which makes use of the duality between confidence intervals and hypothesis testing. We demonstrate the validity of our approach by means of a simulation study and illustrate its practical relevance considering a time‐response case study with toxicological gene expression data.
SMMR High-Dimensional Missing Data & Measurement Error · 发表于 2025-03-19
Betrand Fesuh Nono, Georges Nguefack-Tsague, Martin Kegnenlezom, Eugène-Patrice N Nguéma
摘要
Measurement error is a prevalent issue in high-dimensional generalized linear regression that existing regularization techniques may inadequately address. Most require estimating error distributions, which can be computationally prohibitive or unrealistic. We introduce an error distribution-free approach for variable selection called the Iterative Matrix Uncertainty Selector (IMUS). IMUS employs the matrix uncertainty selector framework for linear models, which is known for its selection consistency properties. It features an efficient iterative algorithm easily implemented for any generalized linear model within the exponential family. Empirically, we demonstrate that IMUS performs well in simulations and on three microarray gene expression datasets, achieving effective covariate selection with smoother convergence and clearer elbow criteria compared to other error distribution free methods. Notably, simulation studies in logistic and Poisson regression showed that IMUS exhibited smoother convergence and clearer elbow criteria, performing comparably to the Generalized Matrix Uncertainty Selector (GMUS) and Generalized Matrix Uncertainty Lasso (GMUL) in covariate selection. In many scenarios, IMUS had smaller estimation errors than GMUL and GMUS, measured by both the 1- and 2-norms. In applications to three microarray datasets with noisy measurements, GMUS faced convergence issues, while GMUL converged but lacked well-defined elbows for two datasets. In contrast, IMUS converged with well-defined elbows for all datasets, providing a potentially effective solution for high dimensional regression problems involving measurement errors.
SiM Survival Analysis Nonparametric & Semiparametric · 发表于 2025-03-19
Nixon Jerez‐Lillo, Alejandra Tapia, Victor Hugo Lachos, Pedro Luiz Ramos
摘要
Kidney cancer, a potentially life‐threatening malignancy affecting the kidneys, demands early detection and proactive intervention to enhance prognosis and survival. Advancements in medical and health sciences and the emergence of novel treatments are expected to lead to a favorable response in a subset of patients. This, in turn, is anticipated to enhance overall survival and disease‐free survival rates. Cure fraction models have become essential for estimating the proportion of individuals considered cured and free from adverse events. This article presents a novel piecewise power‐law cure fraction model with a piecewise decreasing hazard function, deviating from the traditional piecewise constant hazard assumption. By analyzing real medical data, we evaluate various factors to explain the survival of individuals. Consistently, positive outcomes are observed, affirming the significant potential of our approach. Furthermore, we use a local influence analysis to detect potentially influential individuals and perform a postdeletion analysis to analyze their impact on our inferences.
SiM Bayesian Methods Diagnostics & Prediction · 发表于 2025-03-18
Daria Semochkina, Cathal D. Walsh
摘要
Disease models are used to examine the likely impact of therapies, interventions, and public policy changes. Ensuring that these are well calibrated on the basis of available data and that the uncertainty in their projections is properly quantified is an important part of the process. The question of non‐identifiability poses a challenge to disease model calibration where multiple parameter sets generate identical model outputs. For statisticians evaluating the impact of policy interventions such as screening or vaccination, this is a critical issue. This study explores the use of the Bayesian framework to provide a natural way to calibrate models and address non‐identifiability in a probabilistic fashion in the context of disease modeling. We present Bayesian approaches for incorporating expert knowledge and external data to ensure that appropriately informative priors are specified on the joint parameter space. These approaches are applied to two common disease models: a basic susceptible‐infected‐susceptible (SIS) model and a much more complex agent‐based model which has previously been used to address public policy questions in HPV and cervical cancer. The conditions that allow the problem of non‐identifiability to be resolved are demonstrated for the SIS model. For the larger HPV model, an overview of the findings is presented, but of key importance is a discussion on how the non‐identifiability impacts the calibration process. Through case studies, we demonstrate how informative priors can help resolve non‐identifiability and improve model inference. We also discuss how sensitivity analysis can be used to assess the impact of prior specifications on model results. Overall, this work provides an important tutorial for researchers interested in applying Bayesian methods to calibrate models and handle non‐identifiability in disease models.
JASA High-Dimensional · 发表于 2025-03-18
Shushu Zhang, Xuming He, Kean Ming Tan, Wen-Xin Zhou
摘要
Expected shortfall is defined as the average over the tail below (or above) a certain quantile of a probability distribution. Expected shortfall regression provides powerful tools for learning the relationship between a response variable and a set of covariates while exploring the heterogeneous effects of the covariates. In the health disparity research, for example, the lower/upper tail of the conditional distribution of a health-related outcome, given high-dimensional covariates, is often of importance. Under sparse models, we propose the lasso-penalized expected shortfall regression and establish non-asymptotic error bounds, depending explicitly on the sample size, dimension, and sparsity, for the proposed estimator. To perform statistical inference on a covariate of interest, we propose a debiased estimator and establish its asymptotic normality, from which asymptotically valid tests can be constructed. We illustrate the finite sample performance of the proposed method through numerical studies and a data application on health disparity. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*
Biometrics Longitudinal Data Missing Data & Measurement Error · 发表于 2025-03-17
Qian Ye, Lang Wu, Viviane Dias Lima
摘要
In longitudinal data analyses, the within-individual repeated measurements often exhibit large variations and these variations appear to change over time. Understanding the nature of the within-individual systematic and random variations allows us to conduct more efficient statistical inferences. Motivated by human immunodeficiency virus (HIV) viral dynamic studies, we considered a nonlinear mixed effects model for modeling the longitudinal means, together with a model for the within-individual variances which also allows us to address outliers in the repeated measurements. Statistical inference was then based on a joint model for the mean and variance, implemented by a computationally efficient approximate method. Extensive simulations evaluated the proposed method. We found that the proposed method produces more efficient estimates than the corresponding method without modeling the variances. Moreover, the proposed method provides robust inference against outliers. The proposed method was applied to a recent HIV-related dataset, with interesting new findings.
SiM Causal Inference Clinical Trials · 发表于 2025-03-17
Michele Santacatterina, Federico Macchiavelli Giron, Xinyi Zhang, Iván Díaz
摘要
Platform trials are multi‐arm designs that simultaneously evaluate multiple treatments for a single disease within the same overall trial structure. Unlike traditional randomized controlled trials, they allow treatment arms to enter and exit the trial at distinct times while maintaining a control arm throughout. This control arm comprises both concurrent controls, where participants are randomized concurrently to either the treatment or control arm, and non‐concurrent controls, who enter the trial when the treatment arm under study is unavailable. While flexible, platform trials introduce the challenge of using non‐concurrent controls, raising questions about estimating treatment effects. Specifically, which estimands should be targeted? Under what assumptions can these estimands be identified and estimated? Are there any efficiency gains? In this article, we discuss issues related to the identification and estimation assumptions of common choices of estimand. We conclude that the most robust strategy to increase efficiency without imposing unwarranted assumptions is to target the concurrent average treatment effect (cATE), the ATE among only concurrent units, using a covariate‐adjusted doubly robust estimator. Our studies suggest that, for the purpose of obtaining efficiency gains, collecting important prognostic variables is more important than relying on non‐concurrent controls. We also discuss the perils of targeting ATE due to an untestable extrapolation assumption that will often be invalid. We provide simulations illustrating our points and an application to the ACTT platform trial, resulting in a 20% improvement in precision compared to the naive estimator that ignores non‐concurrent controls and prognostic variables.
SiM Other · 发表于 2025-03-17
Yuan Wu, Ryan A. Simmons, Baoshan Zhang, Jesse D. Troy
摘要
Group sequential trials include interim monitoring points to potentially reach futility or efficacy decisions early. This approach to trial design can safeguard patients, provide efficacious treatments for patients early, and save money and time. Group sequential methods are well developed for bell‐shaped continuous, binary, and time‐to‐event outcomes. In this paper, we propose a group sequential design using the Mann‐Whitney‐Wilcoxon test for general two‐sample ordinal data. We establish that the proposed test statistic has asymptotic normality and that sequential statistics satisfy the assumptions of Brownian motion. We also include results of finite sample simulation studies that show our proposed approach has the advantage over existing methods for controlling Type I errors while maintaining power for small sample sizes. A real data set is used to illustrate the proposed method and a sample size calculation approach is proposed for designing new studies.
JASA Causal Inference Meta-Analysis & Data Integration · 发表于 2025-03-17
Larry Han, Jue Hou, Kelly Cho, Rui Duan, Tianxi Cai
摘要
Federated learning of causal estimands may greatly improve estimation efficiency by leveraging data from multiple study sites, but robustness to heterogeneity and model misspecifications is vital for ensuring validity. We develop a Federated Adaptive Causal Estimation (FACE) framework to incorporate heterogeneous data from multiple sites to provide treatment effect estimation and inference for a flexibly specified target population of interest. FACE accounts for site-level heterogeneity in the distribution of covariates through density ratio weighting. To safely incorporate source sites and avoid negative transfer, we introduce an adaptive weighting procedure via a penalized regression, which achieves both consistency and optimal efficiency. Our strategy is communication-efficient and privacy-preserving, allowing participating sites to share summary statistics only once with other sites. We conduct both theoretical and numerical evaluations of FACE and apply it to conduct a comparative effectiveness study of BNT162b2 (Pfizer) and mRNA-1273 (Moderna) vaccines on COVID-19 outcomes in U.S. veterans using electronic health records from five VA regional sites. We show that compared to traditional methods, FACE meaningfully increases the precision of treatment effect estimates, with reductions in standard errors ranging from 26% to 67%. *(abstract via PubMed)*
SiM Meta-Analysis & Data Integration · 发表于 2025-03-17
Zhanfeng Wang, Jingyu Huang, Yuan‐chin Ivan Chang
摘要
Handling massive datasets poses a significant challenge in modern data analysis, particularly within epidemiology and medicine. In this study, we introduce a novel approach using sequential ensemble learning to effectively analyze extensive datasets. Our method prioritizes efficiency from both statistical and computational perspectives, addressing challenges such as data communication and privacy, as discussed in federated learning literature. To demonstrate the efficacy of our approach, we present compelling real‐world examples using COVID‐19 data alongside simulation studies.
Biometrics Bayesian Methods Networks & Graphs · 发表于 2025-03-17
Xiaomeng Ju, Hyung G Park, Thaddeus Tarpey
摘要
This paper presents a Bayesian regression model relating scalar outcomes to brain functional connectivity represented as symmetric positive definite (SPD) matrices. Unlike many proposals that simply vectorize the matrix-valued connectivity predictors, thereby ignoring their geometric structure, the method presented here respects the Riemannian geometry of SPD matrices by using a tangent space modeling. Dimension reduction is performed in the tangent space, relating the resulting low-dimensional representations to the responses. The dimension reduction matrix is learned in a supervised manner with a sparsity-inducing prior imposed on a Stiefel manifold to prevent overfitting. Our method yields a parsimonious regression model that allows uncertainty quantification of all model parameters and identification of key brain regions that predict the outcomes. We demonstrate the performance of our approach in simulation settings and through a case study to predict Picture Vocabulary scores using data from the Human Connectome Project.
Biometrics Causal Inference Bayesian Methods Nonparametric & Semiparametric · 发表于 2025-03-17
Chanmin Kim, Corwin Zigler
摘要
Principal stratification analysis evaluates how causal effects of a treatment on a primary outcome vary across strata of units defined by their treatment effect on some intermediate quantity. This endeavor is substantially challenged when the intermediate variable is continuously scaled and there are infinitely many basic principal strata. We employ a Bayesian nonparametric approach to flexibly evaluate treatment effects across flexibly modeled principal strata. The approach uses Bayesian Causal Forests (BCF) to simultaneously specify 2 Bayesian Additive Regression Tree models; one for the principal stratum membership and one for the outcome, conditional on principal strata. We show how the capability of BCF for capturing treatment effect heterogeneity is particularly relevant for assessing how treatment effects vary across the surface defined by continuously scaled principal strata, in addition to other benefits relating to targeted selection and regularization-induced confounding. The capabilities of the proposed approach are illustrated with a simulation study, and the methodology is deployed to investigate how causal effects of power plant emissions control technologies on ambient particulate pollution vary as a function of the technologies’ impact on sulfur dioxide emissions.
SiM Survival Analysis Clinical Trials · 发表于 2025-03-17
Moritz Fabian Danzer, Ina Dormuth
摘要
When planning a clinical trial for a time‐to‐event endpoint, we require an estimated effect size and need to consider the type of effect. Usually, an effect of proportional hazards is assumed with the hazard ratio as the corresponding effect measure. Thus, the standard procedure for survival data is generally based on a single‐stage log‐rank test. Knowing that the assumption of proportional hazards is often violated and sufficient knowledge to derive reasonable effect sizes is usually unavailable, such an approach is relatively rigid. We introduce a more flexible procedure by combining two methods designed to be more robust in case we have little to no prior knowledge. First, we employ a more flexible adaptive multi‐stage design instead of a single‐stage design. Second, we apply combination‐type tests in the first stage of our suggested procedure to benefit from their robustness under uncertainty about the deviation pattern. We can then use the data collected during this period to choose a more specific single‐weighted log‐rank test for the subsequent stages. In this step, we employ Royston‐Parmar spline models to extrapolate the survival curves to make a reasonable decision. Based on a real‐world data example, we show that our approach can save a trial that would otherwise end with an inconclusive result. Additionally, our simulation studies demonstrate a sufficient power performance while maintaining more flexibility.
Biometrics Other · 发表于 2025-03-17
Ying Cui, Qi Yu, Amita Manatunga, Jeong Hoon Jang
摘要
A common practice for establishing the reliability of a new computer-aided diagnostic (CAD) device is to evaluate how well its clinical measurements agree with those of a gold standard test. However, in many clinical studies, a gold standard is unavailable, and one needs to aggregate information from multiple imperfect reference standards for evaluation. A key challenge here is the heterogeneity in diagnostic accuracy across different reference standards, which may lead to biased evaluation of a device if improperly accounted for during the aggregation process. We propose an intuitive and easy-to-use statistical framework for evaluation of a device by assessing agreement between its measurements and the weighted sum of measurements from multiple imperfect reference standards, where weights representing relative reliability of each reference standard are determined by a model-free, unsupervised inductive procedure. Specifically, the inductive procedure recursively assigns higher weights to reference standards whose assessments are more consistent with each other and form a majority opinion, while assigning lower weights to those with greater discrepancies. Unlike existing methods, our approach does not require any modeling assumptions or external data to quantify heterogeneous accuracy levels of reference standards. It only requires specifying an appropriate agreement index used for weight assignment and device evaluation. The framework is applied to evaluate a CAD device for kidney obstruction by comparing its diagnostic ratings with those of multiple nuclear medicine physicians.
SiM Clinical Trials · 发表于 2025-03-14
Ann Marie K. Weideman, Kevin J. Anstrom, Gary G. Koch, Xianming Tan
摘要
Sample size re‐estimation (SSR) at an interim analysis allows for adjustments based on accrued data. Existing strategies rely on either blinded or unblinded methods to inform such adjustments and, ideally, perform these adjustments in a way that preserves Type I error at the nominal level. Here, we propose an approach that uses partially‐unblinded methods for SSR for both binary and continuous endpoints. Although this approach has operational unblinding, its partial use of the unblinded information for SSR does not include the interim effect size, hence the term ‘partially‐unblinded.’ Through proof‐of‐concept and simulation studies, we demonstrate that these adjustments can be made without compromising the Type I error rate. We also investigate different mathematical expressions for SSR under different variance scenarios: homogeneity, heterogeneity, and a combination of both. Of particular interest is the third form of dual variance, for which we provide additional clarifications for binary outcomes and derive an analogous form for continuous outcomes. We show that the corresponding mathematical expressions for the dual variance method are a compromise between those for variance homogeneity and heterogeneity, resulting in sample size estimates that are bounded between those produced by the other expressions, and extend their applicability to adaptive trial design.
SiM Bayesian Methods · 发表于 2025-03-14
Madeleine E. St. Ville, Christopher S. McMahan, Joe D. Bible, Joshua M. Tebbs, Christopher R. Bilder
摘要
When screening for low‐prevalence diseases, pooling specimens (e.g., blood, urine, swabs, etc.) through group testing has the potential to substantially reduce costs when compared to testing specimens individually. A common goal in group testing applications is to estimate the relationship between an individual's true disease status and their individual‐level covariate information. However, estimating such a relationship is a non‐trivial problem because true individual disease statuses are unknown due to the group testing protocol and the possibility of imperfect testing. While several regression methods have been developed in recent years to accommodate the complexity of group testing data, the functional form of covariate effects is typically assumed to be known. To avoid model misspecification and to provide a more flexible approach, we propose a Bayesian additive regression trees framework to model the individual‐level probability of disease with potentially misclassified group testing data. Our methods can be used to analyze data arising from any group testing protocol with the goal of estimating unknown functions of covariates and assay classification accuracy probabilities.
SiM Longitudinal Data Missing Data & Measurement Error Survival Analysis · 发表于 2025-03-13
Tetiana Gorbach, James R. Carpenter, Chris Frost, Maria Josefsson, Jennifer Nicholas, Lars Nyberg
摘要
Motivated by the Swedish Betula study, we consider the joint modeling of longitudinal memory assessments and the hazard of dementia. In the Betula data, the time‐to‐dementia onset or its absence is available for all participants, while some memory measurements are missing. In longitudinal studies of aging, one cannot rule out the possibility of dropout due to health issues resulting in missing not at random longitudinal measurements. We, therefore, propose a pattern‐mixture sensitivity analysis for missing not‐at‐random data in the joint modeling framework. The sensitivity analysis is implemented via multiple imputation as follows: (i) multiply impute missing not at random longitudinal measurements under a set of plausible pattern‐mixture imputation models that allow for acceleration of memory decline after dropout, (ii) fit the joint model to each imputed longitudinal memory and time‐to‐dementia dataset, and (iii) combine the results of step (ii). Our work illustrates that sensitivity analyses via multiple imputations are an accessible, pragmatic method to evaluate the consequences of missing not at‐random data on inference and prediction. This flexible approach can accommodate a range of models for the longitudinal and event‐time processes. In particular, the pattern‐mixture modeling approach provides an accessible way to frame plausible missing not at random assumptions for different missing data patterns. Applying our approach to the Betula study shows that worse memory levels and steeper memory decline were associated with a higher risk of dementia for all considered scenarios.
JASA Networks & Graphs · 发表于 2025-03-13
José Á. Sánchez Gómez, Weibin Mo, Junlong Zhao, Yufeng Liu
摘要
Graphical models are popular tools for exploring relationships among a set of variables. The Gaussian graphical model (GGM) is an important class of graphical models, where the conditional dependence among variables is represented by nodes and edges in a graph. In many real applications, we are interested in detecting hubs in graphical models, which refer to nodes with a significant higher degree of connectivity compared to non-hub nodes. A typical strategy for hub detection consists of estimating the graphical model, and then using the estimated graph to identify hubs. Despite its simplicity, the success of this strategy relies on the accuracy of the estimated graph. In this paper, we directly target on the estimation of hubs, without the need of estimating the graph. We establish a novel connection between the presence of hubs in a graphical model, and the spectral decomposition of the underlying covariance matrix. Based on this connection, we propose the method of inverse principal components for hub detection (IPC-HD). Both consistency and convergence rates are established for IPC-HD. Our simulation study demonstrates the superior performance and fast computation of the proposed method compared to existing methods in the literature in terms of hub detection. Our application to a prostate cancer gene expression dataset detects several hub genes with close connections to tumor development. *(abstract via OpenAlex)*
SiM Causal Inference Machine Learning Survival Analysis · 发表于 2025-03-13
Denis Talbot, Awa Diop, Miceline Mésidor, Yohann Chiu, Caroline Sirois, Andrew J. Spieker, Antoine Pariente, Pernelle Noize, Marc Simard, Miguel Angel Luque Fernandez, Michael Schomaker, Kenji Fujita, Danijela Gnjidic, Mireille E. Schnitzer
摘要
Targeted maximum likelihood estimation (TMLE) is an increasingly popular framework for the estimation of causal effects. It requires modeling both the exposure and outcome but is doubly robust in the sense that it is valid if at least one of these models is correctly specified. In addition, TMLE allows for flexible modeling of both the exposure and outcome with machine learning methods. This provides better control for measured confounders since the model specification automatically adapts to the data, instead of needing to be specified by the analyst a priori . Despite these methodological advantages, TMLE remains less popular than alternatives in part because of its less accessible theory and implementation. While some tutorials have been proposed, none address the case of a time‐to‐event outcome. This tutorial provides a detailed step‐by‐step explanation of the implementation of TMLE for estimating the effect of a point binary or multilevel exposure on a time‐to‐event outcome, modeled as counterfactual survival curves and causal hazard ratios. The tutorial also provides guidelines on how best to use TMLE in practice, including aspects related to study design, choice of covariates, controlling biases and use of machine learning. R‐code is provided to illustrate each step using simulated data ( https://github.com/detal9/SurvTMLE ). To facilitate implementation, a general R function implementing TMLE with options to use machine learning is also provided. The method is illustrated in a real‐data analysis concerning the effectiveness of statins for the prevention of a first cardiovascular disease among older adults in Québec, Canada, between 2013 and 2018.
SiM Bayesian Methods Diagnostics & Prediction Machine Learning · 发表于 2025-03-13
Connor Robertson, Cosmin Safta, Nicholson Collier, Jonathan Ozik, Jaideep Ray
摘要
Agent‐based models (ABM) provide an excellent framework for modeling outbreaks and interventions in epidemiology by explicitly accounting for diverse individual interactions and environments. However, these models are usually stochastic and highly parametrized, requiring precise calibration for predictive performance. When considering realistic numbers of agents and properly accounting for stochasticity, this high‐dimensional calibration can be computationally prohibitive. This paper presents a random forest‐based surrogate modeling technique to accelerate the evaluation of ABMs and demonstrates its use to calibrate an epidemiological ABM named CityCOVID via Markov chain Monte Carlo (MCMC). The technique is first outlined in the context of CityCOVID's quantities of interest, namely hospitalizations and deaths, by exploring dimensionality reduction via temporal decomposition with principal component analysis (PCA) and via sensitivity analysis. The calibration problem is then presented, and samples are generated to best match COVID‐19 hospitalization and death numbers in Chicago from March to June in 2020. These results are compared with previous approximate Bayesian calibration (IMABC) results, and their predictive performance is analyzed, showing improved performance with a reduction in computation.
Biometrics Spatial & Time Series Nonparametric & Semiparametric · 发表于 2025-03-12
Guangyu Yang, Baqun Zhang, Min Zhang
摘要
The segmented model has significant applications in scientific research when the change-point effect exists. In this article, we propose a comprehensive semiparametric framework in segmented models to test the existence and estimate the location of change points in the generalized outcome setting. The proposed framework is based on a semismooth estimating equation for the change-point estimation and an average score-type test for hypothesis testing. The root-n consistency, asymptotic normality, and asymptotic efficiency of estimators for all parameters in the segmented model are rigorously studied. The distribution of the average score-type test statistics under the null hypothesis is rigorously derived. Extensive simulation studies are conducted to assess the numerical performance of the proposed change-point estimation method and the average score-type test. We investigate change-point effects of baseline glomerular filtration rate and body mass index on bleeding after intervention using data from Blue Cross Blue Shield. This application study successfully identifies statistically significant change-point effects, with the estimated values providing clinically meaningful insights.